These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 4053123)

  • 1. Evaluation of screening tests for pheochromocytoma.
    Hengstmann JH
    Cardiology; 1985; 72 Suppl 1():153-6. PubMed ID: 4053123
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Strategy for the biochemical study of pheochromocytoma].
    Peyrin L
    Ann Med Interne (Paris); 1983; 134(3):235-7. PubMed ID: 6625418
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictive factors for malignant pheochromocytoma: analysis of 136 patients.
    Feng F; Zhu Y; Wang X; Wu Y; Zhou W; Jin X; Zhang R; Sun F; Kasoma Z; Shen Z
    J Urol; 2011 May; 185(5):1583-90. PubMed ID: 21419457
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pheochromocytoma: rediscovery as a catecholamine-metabolizing tumor.
    Eisenhofer G; Goldstein DS; Kopin IJ; Crout JR
    Endocr Pathol; 2003; 14(3):193-212. PubMed ID: 14586065
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Biochemical diagnosis of pheochromocytoma by determining normetanephrine and metanephrine concentrations in single voided urine].
    Jibiki K; Demura H; Naruse M; Demura R; Ito Y; Sakurai H; Abe Y; Naruse K; Nomura K; Odagiri E
    Nihon Naibunpi Gakkai Zasshi; 1988 Aug; 64(8):707-16. PubMed ID: 3224727
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overnight excretion of urinary catecholamines and metabolites in the detection of pheochromocytoma.
    Peaston RT; Lennard TW; Lai LC
    J Clin Endocrinol Metab; 1996 Apr; 81(4):1378-84. PubMed ID: 8636337
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monoamine oxidase A down-regulation contributes to high metanephrine concentration in pheochromocytoma.
    Grouzmann E; Matter M; Bilz S; Herren A; Triponez F; Henzen C; Kim KS; Zulewski H; Buclin T; Brakch N; Abid K
    J Clin Endocrinol Metab; 2012 Aug; 97(8):2773-81. PubMed ID: 22569243
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Catecholamines and their derivatives in the study of pheochromocytoma].
    Zoghbi F; Landault C; Salmon N; Legrand JC
    Ann Med Interne (Paris); 1983; 134(3):230-2. PubMed ID: 6625416
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Diagnostic difficulties in recognizing of pheochromocytoma].
    Przybylik-Mazurek E; Buziak-Bereza M; Stochmal E; Budzyński A; Białas M; Kostecka-Matyja M; Hubalewska-Dydejczyk A
    Przegl Lek; 2010; 67(12):1276-81. PubMed ID: 21591353
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnosis of endocrine disease: Biochemical diagnosis of phaeochromocytoma and paraganglioma.
    van Berkel A; Lenders JW; Timmers HJ
    Eur J Endocrinol; 2014 Mar; 170(3):R109-19. PubMed ID: 24347425
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical diagnosis of pheochromocytoma and paraganglioma-induced secondary hypertension through UPLC-MS/MS analysis of plasma catecholamines and their metabolites.
    Zhang W; Li X; Li W; Zhang Y; Cai J; Feng S; Sun Z
    J Clin Hypertens (Greenwich); 2024 Apr; 26(4):416-424. PubMed ID: 38459755
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Analysis of laboratory data of 155 patients with pheochromocytoma-paraganglioma syndrome diagnosed during the past 20 years].
    Balog B; Tőke J; Róna K; Szücs N; Igaz P; Pusztai P; Sármán B; Gláz E; Kiss R; Patócs A; Rácz K; Tóth M
    Orv Hetil; 2015 Apr; 156(16):626-35. PubMed ID: 25864138
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The diagnosis of atypical pheochromocytoma: a challenge for the biologist as well].
    Peyrin L; Cottet-Emard JM; Cottet-Emard RM; Vouillarmet A
    Pathol Biol (Paris); 2001 Apr; 49(3):247-54. PubMed ID: 11367560
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New advances in the biochemical diagnosis of pheochromocytoma: moving beyond catecholamines.
    Lenders JW; Pacak K; Eisenhofer G
    Ann N Y Acad Sci; 2002 Sep; 970():29-40. PubMed ID: 12381539
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of plasma metanephrines measured by a commercial immunoassay and urinary catecholamines in the diagnosis of pheochromocytoma.
    Christensen TT; Frystyk J; Poulsen PL
    Scand J Clin Lab Invest; 2011 Dec; 71(8):695-700. PubMed ID: 22023043
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Biological diagnosis of pheochromocytomas and paragangliomas].
    d'Herbomez M; Rouaix N; Bauters C; Wémeau JL
    Presse Med; 2009 Jun; 38(6):927-34. PubMed ID: 19135846
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pheochromocytoma: clinical review based on a rare case in adolescence.
    Alface MM; Moniz P; Jesus S; Fonseca C
    BMJ Case Rep; 2015 Aug; 2015():. PubMed ID: 26243750
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The diagnosis of pheochromocytoma. Overnight excretion of catecholamine metabolites.
    Sullivan JM; Solomon HS
    JAMA; 1975 Feb; 231(6):618-9. PubMed ID: 1172846
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Urinary normetanephrine and metanephrine measured by radioimmunoassay for the diagnosis of pheochromocytoma: utility of 24-hour and random 1-hour urine determinations.
    Oishi S; Sasaki M; Ohno M; Sato T
    J Clin Endocrinol Metab; 1988 Sep; 67(3):614-8. PubMed ID: 3410942
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biochemical tests for pheochromocytoma: strategies in hypertensive patients.
    Young MJ; Dmuchowski C; Wallis JW; Barnas GP; Shapiro B
    J Gen Intern Med; 1989; 4(4):273-6. PubMed ID: 2668458
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.